Sex Drive, Erectile Dysfunction, and GLP-1 Side Effects

Ozempic and Sex: The Surprising Sexual Side Effects of GLP-1s

Ozempic and Sex: The Surprising Sexual Side Effects of GLP-1s
Mariia Vitkovska /iStock

You may notice changes to your sexual performance and love life if you take glucagon-like peptide-1 (GLP-1) agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepound, Mounjaro). These medications are prescribed primarily to address blood sugar issues and weight loss, but they can also affect your brain, personality, and self-esteem, potentially leading to changes in the bedroom, for better or worse.

Although some sexual side effects of GLP-1s may be related to the medications themselves, others come from weight loss or changes to body image. Most research into the sexual side effects of GLP-1 medications is still very preliminary, and the reports on these changes are driven by anecdotes and social media as much as they are by clinical trials.

1. Sex Drive

Some researchers have begun to investigate how GLP-1 drugs might affect your libido, or sex drive.

A survey of social media comments found that most GLP-1 users who commented on changes to their sex life reported increased sex drive and sexual arousal.

But that experience isn’t universal: Some people report a reduced desire to have sex or a generally muted response to sex shortly after taking the medications.

Libido-related GLP-1 research is thin. But Chris Szoke, NP, CDCES, a nurse practitioner based in Tucson, Arizona, points to the impact of GLP-1 medications on digestion, appetite suppression, and changes to hormones such as dopamine that “reward” the brain. These medications appear to affect the reward centers of the brain.

“It’s not surprising [that GLP-1 medications] might also affect other forms of pleasure, including sex,” Szoke says.

Szoke adds that he has had patients who have seen a boost to their sex drive after starting a GLP-1 medication but that it’s hard to tell if that’s related to the drug or the weight loss.

“Their self-esteem and confidence might be up,” he says. “But what if the drug helped them start drinking less or smoking less marijuana? It’s all connected. We can’t pinpoint one cause or effect without more research.”

Weight loss can boost testosterone in men and increase libido, but it also can reduce testosterone and sex drive in women, according to research.

“It’s very plausible that losing weight with help from a GLP-1 can boost your sex drive, not because of the GLP-1, but simply because of the weight loss, especially the fat around the abdomen,” Szoke says.

2. Inability to Orgasm

Some men and women who take GLP-1s have reported difficulty achieving orgasm, also known as anorgasmia.

One explanation may be vasoconstriction, or tightening of the smooth muscles around blood vessels, reducing oxygen and blood flow to a person’s genitals and interfering with genital arousal.

Because GLP-1 medications decrease the neurotransmitters dopamine and norepinephrine, they may also dampen arousal and the ability to orgasm.

3. Increased Fertility

GLP-1 medications such as Ozempic have been connected to increased fertility among women.

There isn’t enough data yet to form conclusions on how GLP-1 medications affect fertility, and women who are pregnant or planning on becoming pregnant are urged not to use these drugs. But GLP-1s do help with weight loss, which can increase fertility, partially by decreasing inflammation and improving hormonal production.

Even a 5 percent reduction in body weight can help balance a woman’s hormone levels, restore menstrual cycles, and increase ovulation. Modest weight loss is associated with high conception and pregnancy rates, especially in people with polycystic ovarian syndrome (PCOS).

“If a woman is living with obesity, this means there is likely also significant inflammation and potentially abnormal testosterone levels,” says Szoke, adding that obesity can affect ovulation and menstrual cycles, as well.

Weight loss can also increase a man’s fertility by improving sperm count, overall sexual function, and reproductive organ health.

4. Erectile Dysfunction

Some males have reported having erectile dysfunction while taking GLP-1s, though others have noted an opposite effect.

One study of people without diabetes found that 1.4 percent of males reported erectile dysfunction while taking semaglutide, compared with 0.14 percent of males not taking it. Researchers pointed primarily to changes in smooth muscle function as the reason, along with the impact of GLP-1 receptors on steady testosterone flow.

Other research, however, has come to the exact opposite conclusion: GLP-1 medications can improve sexual function, with a 50 percent decrease in risk of erectile dysfunction. The medications may enhance sexual function by improving or preventing conditions like obesity, type 2 diabetes, and heart disease, all of which can cause sexual issues.

“If losing a lot of weight improved a person’s blood pressure levels, for example, then they’ll probably see a boost in their ability to get and maintain an erection,” Szoke says. “But some people might be more susceptible to the effects on smooth muscle function.”

Erectile dysfunction could be the sign of other health issues unrelated to GLP-1 medications. Contact your healthcare provider if you are experiencing symptoms.

5. Premature Ejaculation

In addition to erectile dysfunction, some males have reported ejaculating sooner than wanted during sex, known as premature ejaculation, while taking GLP-1 medications.

An analysis of insurance claims from more than 500,000 males on GLP-1 medications found that they had increased odds of experiencing premature ejaculation, as well as inability to orgasm and erectile dysfunction. This was true among men both with and without diabetes and obesity.

Premature ejaculation has a variety of potential causes, some physical and some mental.

Diabetes and obesity are considered risk factors, in addition to heart disease, high blood pressure, and other conditions affecting hormone balance, such as hyperthyroidism.

6. Dating Life Changes

A GLP-1 treatment can have a major impact on your love life. Significant weight loss can change your self-esteem, confidence in dating, current relationships, and sexual performance.

One survey of 2,000 single adults showed that 59 percent of GLP-1 users said they saw a change to their dating life after taking GLP-1s, with 17 percent buying new clothes to show off their body and 14 percent saying they made more connections on dating apps.

Not all users report positive changes. Sixteen percent of respondents said they experienced a decrease in sexual desire, compared with 18 percent who saw an increase. Potentially negative effects of weight loss may include saggy skin throughout many areas of the body, side effects commonly referred to with names like “Ozempic butt” or “Ozempic face,” which can negatively affect appearance and self-confidence.

“Sagging skin is really impossible to avoid when you lose a lot of weight quickly,” Szoke says. “While skin removal surgery isn’t always an option, it’s important to also work with a therapist and focus on your mental health throughout this transition. Your weight is not just physical. It is a big part of your identity.”

7. ‘Ozempic Penis’ and ‘Ozempic Vulva’

Some people who have taken GLP-1 medications have said on social media that they have noticed an increase in penis size, weakness in vaginal muscles, or vaginal looseness. Szoke says that GLP-1 medications will not change the size of your sexual organs, despite rumors saying otherwise. These changes are likely the result of weight loss and sagging skin, which can change the appearance of the genital area.

“No, we have no reason to believe Ozempic can suddenly increase the length of your penis,” Szoke says. “But weight loss can have surprising benefits beyond simply reducing the bulk around that area of your body.”

Weight loss with GLP-1s can lead to various changes in the body, Szoke says. Primarily, it may lead to fat loss in unintended areas, including the breasts, buttocks, and even the labia. Men also store body fat around the base of the penis in the groin.

“When you lose a significant amount of body fat quickly, several areas of your body are inevitably going to have that looser skin,” Szoke says. “This can be really hard to deal with, especially in the stomach and the arms. Body fat definitely accumulates in the vaginal area, too.”

The Takeaway

  • Glucagon-like peptide-1 (GLP-1) medications not only help manage weight and diabetes issues but also may have sexual side effects.
  • Changes to libido, ability to have an orgasm, and fertility are among reported GLP-1 side effects.
  • Research is still needed to determine if many side effects are related to medication or other factors, such as weight loss or blood sugar.
  • GLP-1 medications will not change genitalia size, though losing a significant amount of weight could make body parts appear different.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Arillotta D et al. Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights From Social Media Using a Mixed-Methods Approach. Brain Sciences. June 20, 2024.
  2. Mohammed GF et al. Tirzepatide Affect Sexual Function in Women: Case Report. Clinical Medicine Insights: Case Reports. June 6, 2025.
  3. Conley M. 5 Things to Know About GLP-1s and Addiction. Stanford Medicine. April 1, 2025.
  4. Brzozowska MM et al. Sex-Differential Testosterone Response to Long-Term Weight Loss. International Journal of Obesity. July 16, 2024.
  5. Visvabharathy V et al. Anorgasmia Following Initiation of GLP-1 Agonist. Sexual Medicine. June 2025.
  6. Vasoconstriction. Cleveland Clinic. August 9, 2021.
  7. ‘Ozempic Babies’: How GLP-1 Agonists Affect Fertility. Cleveland Clinic. March 10, 2025.
  8. Pavli P et al. Infertility Improvement After Medical Weight Loss in Women and Men. International Journal of Molecular Sciences. February 5, 2024.
  9. Zhou L et al. Effects of GLP1RAs on Pregnancy Rate and Menstrual Cyclicity in Women With Polycystic Ovary Syndrome: A Meta-Analysis and Systematic Review. BMC Endocrine Disorders. November 8, 2023.
  10. Liao B et al. Prescribing Ozempic and Wegovy for Weight Loss Is Associated With an Increased Risk of Erectile Dysfunction and Hypogonadism in Non-Diabetic Males. Journal of Sexual Medicine. February 5, 2024.
  11. An H et al. Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Erectile Dysfunction: A Drug Target Mendelian Randomization Study. Frontiers in Endocrinology. November 13, 2024.
  12. Langroudi AP et al. GLP-1 Receptor Agonists: From Metabolic Benefits to Sexual Health Concerns — an Analysis of UA Insurance Claims Data. Journal of Urology. May 1, 2025.
  13. Cadet L. Beyond Weight Loss: 59 percent of GLP-1 Users Say the Prescription Drug Changed Their Dating Lives. DatingAdvice.com. August 25, 2025.

Diala Alatassi, MD, FACP

Medical Reviewer

Diala Alatassi, MD, is a board-certified obesity medicine specialist who is committed to providing comprehensive, compassionate, and personalized care. By integrating medical expertise with a supportive and motivational approach, Dr. Alatassi fosters a partnership with each patient, guiding them with empathy and respect, to ensure they feel confident and capable of making lasting changes for their overall well-being.

In her free time, she enjoys spending time outdoors with family and friends and traveling.

Ginger Vieira

Author

Ginger Vieira has lived with type 1 diabetes and celiac disease since 1999, and fibromyalgia since 2014. She is the author of Pregnancy with Type 1 Diabetes, Dealing with Diabetes BurnoutEmotional Eating with Diabetesand Your Diabetes Science Experiment.

Ginger is a freelance writer and editor with a bachelor's degree in professional writing, and a background in cognitive coaching, video blogging, record-setting competitive powerlifting, personal training, Ashtanga yoga, and motivational speaking.

She lives in Vermont with a handsome husband, two daughters, and a loyal dog named Pedro.